PRELUDE CAPITAL MANAGEMENT, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$283,718
+36.4%
46,435
+936.3%
0.02%
+240.0%
Q4 2020$208,000
-35.6%
4,481
-54.3%
0.01%
-68.8%
Q3 2020$323,000
+0.9%
9,806
-15.9%
0.02%
-11.1%
Q2 2020$320,000
+32.2%
11,658
+43.9%
0.02%
+12.5%
Q1 2020$242,000
-40.8%
8,099
-45.2%
0.02%0.0%
Q4 2019$409,000
+53.2%
14,768
+0.5%
0.02%
+33.3%
Q3 2019$267,000
+8800.0%
14,693
+9083.1%
0.01%
Q2 2019$3,000
-95.2%
160
-97.1%
0.00%
-100.0%
Q3 2018$62,000
-55.7%
5,500
-50.0%
0.00%
-50.0%
Q2 2018$140,000
-38.6%
11,000
-18.5%
0.01%
-52.9%
Q1 2018$228,000
+185.0%
13,500
+35.0%
0.02%
+183.3%
Q4 2017$80,000
+37.9%
10,000
+33.3%
0.01%
+20.0%
Q3 2017$58,000
-80.1%
7,500
-81.0%
0.01%
-82.1%
Q2 2017$291,00039,5340.03%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
MHR Fund Management 11,997,103$84,459,60511.88%
MPM BioImpact LLC 2,950,118$20,768,8314.18%
Perceptive Advisors 14,036,410$98,816,3262.86%
Velan Capital Investment Management LP 240,000$1,689,6001.57%
Parametrica Management Ltd 96,500$679,3601.31%
Boxer Capital, LLC 3,705,133$26,0841.21%
Soleus Capital Management, L.P. 1,239,777$8,728,0300.97%
Opaleye Management Inc. 421,000$2,963,8400.71%
683 Capital Management, LLC 1,400,000$9,856,0000.71%
RICE HALL JAMES & ASSOCIATES, LLC 1,758,759$12,381,6650.70%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders